Satsuma Pharmaceuticals has presented phase 1 data on its second-generation nasal delivery device. The readout positions Satsuma to start a phase 3 clinical trial designed to enable it to bounce back ...

Tenax Therapeutics (TENX) is in a very good position as far as its drug development plan goes for its drug levosimendan. That's because it is already in the process of running the ongoing phase 3 ...

Tuesday, 26 July 2022: Researchers from RCSI University of Medicine and Health Sciences have developed a new lab-based model of a heart and circulatory system that will help test devices to treat ...

This article is part of a series of profiles on the 2020 winners of the National Academy of Medicine’s Healthy Longevity Catalyst Awards — part of the Healthy Longevity Global Competition, a multiyear ...